Synthetic gene circuits specifically targeting cancer cells are expected to produce multiple immunomodulators, which will be expressed exclusively in the target tumor cells. The circuit will lead to the triggering of a robust long-term anti-tumoral immune response.

link to Circuit Bio page

Breast cancer, CRC

Lior Nissim, PhD – Inventor

Nir Skalka, PhD – CSO